Effect of Linagliptin on Arterial 18 F-Fluorodeoxyglucose Positron Emission Tomography Uptake: A Randomized Controlled Trial (RELEASE)

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-02, Vol.69 (8), p.1097
Main Authors: de Boer, Stefanie A, Heerspink, Hiddo J L, Lefrandt, Joop D, Hovinga-de Boer, Marieke C, van Roon, Arie M, Juárez Orozco, Luis E, Glaudemans, Andor W J M, Kamphuisen, Pieter W, Slart, Riemer H J A, Mulder, Douwe J
Format: Article
Language:English
Subjects:
Administration, Oral
Aged
Arteries - drug effects
Arteries - metabolism
Arteries - physiopathology
Atherosclerosis - diagnosis
Atherosclerosis - metabolism
Atherosclerosis - physiopathology
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - drug therapy
Diabetes Mellitus, Type 2 - metabolism
Dipeptidyl-Peptidase IV Inhibitors - administration & dosage
Fluorodeoxyglucose F18 - pharmacokinetics
Humans
Linagliptin - administration & dosage
Middle Aged
Positron-Emission Tomography - methods
Radiopharmaceuticals - pharmacokinetics
Randomized Controlled Trials as Topic
Vascular Stiffness - physiology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1558-3597